Segar Receives New R21

Jeff Segar received a new R21 from the NIH titled “Fenoldopam to prevent renal dysfunction in indomethacin treated preterm infants”. The grant provides about $419,000 over two years for the project. Congratulations, Dr. Segar!

Leave a Reply

Your email address will not be published. Required fields are marked *